AU6240999A - Laminin 5 for treatment of bone defects - Google Patents

Laminin 5 for treatment of bone defects

Info

Publication number
AU6240999A
AU6240999A AU62409/99A AU6240999A AU6240999A AU 6240999 A AU6240999 A AU 6240999A AU 62409/99 A AU62409/99 A AU 62409/99A AU 6240999 A AU6240999 A AU 6240999A AU 6240999 A AU6240999 A AU 6240999A
Authority
AU
Australia
Prior art keywords
laminin
treatment
bone defects
bone
defects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62409/99A
Inventor
Bryan J. Tucker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Desmos Inc
Original Assignee
Desmos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Desmos Inc filed Critical Desmos Inc
Publication of AU6240999A publication Critical patent/AU6240999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU62409/99A 1998-09-01 1999-08-27 Laminin 5 for treatment of bone defects Abandoned AU6240999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14538798A 1998-09-01 1998-09-01
US09145387 1998-09-01
PCT/US1999/019773 WO2000012690A2 (en) 1998-09-01 1999-08-27 Laminin 5 for treatment of bone defects

Publications (1)

Publication Number Publication Date
AU6240999A true AU6240999A (en) 2000-03-21

Family

ID=22512881

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62409/99A Abandoned AU6240999A (en) 1998-09-01 1999-08-27 Laminin 5 for treatment of bone defects

Country Status (3)

Country Link
AU (1) AU6240999A (en)
CA (1) CA2348743A1 (en)
WO (1) WO2000012690A2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5654990A (en) * 1989-04-28 1990-11-29 Brigham And Women's Hospital Novel materials and methods for guided tissue regeneration
EP0716659A4 (en) * 1993-09-02 1998-09-02 Hutchinson Fred Cancer Res Epiligrin, an epithelial ligand for integrins
CA2250215A1 (en) * 1996-03-29 1997-10-09 Desmos, Inc. Cellular attachment to laminin 5-coated trans-epithelial appliances
WO1998031798A1 (en) * 1997-01-16 1998-07-23 Human Genome Sciences, Inc. Human extracellular matrix-1

Also Published As

Publication number Publication date
WO2000012690A9 (en) 2001-01-04
CA2348743A1 (en) 2000-03-09
WO2000012690A2 (en) 2000-03-09
WO2000012690A3 (en) 2000-05-25

Similar Documents

Publication Publication Date Title
AU1727400A (en) Apparatus for thermal treatment of tissue
AU1434097A (en) Preparation of biological material for implants
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
AU1835097A (en) Surface modification of medical implants
AU4988997A (en) Compositions and methods for treating bone deficit conditions
EP0907723A4 (en) Enzyme composition for tissue dissociation
ZA989150B (en) Mouth hygienic composition for the treatment of halitosis
AU4015597A (en) Process for producing bone cement containing active substances
AU7471096A (en) Compositions and methods for treating bone deficit conditions
AU698509B2 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
AU2270597A (en) Method of sterilization of bone tissue
GB2311940B (en) Pharmaceutical compositions for the treatment of rhinitis
HUP0000538A3 (en) Process for disinfecting instruments
AU3784999A (en) Methods for treatment of pain
AU1714697A (en) Method and composition for the treatment of osteoarthritis
AU1697197A (en) Immunoconjugate for the treatment of aids
AU5427398A (en) Cytoperfusion of tissue specimens
AU4393497A (en) Method for the sterilization of biological materials
AU1878201A (en) Composition for the treatment of damaged tissue
HUP9903852A3 (en) Process for the preparation of contrast agents
AU4480997A (en) Screening methods for compounds useful in the treatment of schizophrenia
AU6883398A (en) Methods of treating bone loss
EP1096927A4 (en) Composition for treatment of stress
IL137439A0 (en) Method for the determination of prosthetic infections
AU2420101A (en) Method and composition for the treatment of pain

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase